Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.2004
+0.0108 (5.70%)
At close: Sep 15, 2025, 4:00 PM EDT
0.1960
-0.0044 (-2.20%)
After-hours: Sep 15, 2025, 7:48 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $10.09 million as of September 15, 2025. Its market cap has increased by 113.65% in one year.
Market Cap
10.09M
Enterprise Value
3.18M
1-Year Change
113.65%
Ranking
Category
Stock Price
$0.20
Market Cap Chart
Since October 9, 2017, Processa Pharmaceuticals's market cap has decreased from $1.04B to $10.09M, a decrease of -99.03%. That is a compound annual growth rate of -44.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 9.55M | 230.62% |
| Dec 31, 2024 | 2.89M | -64.97% |
| Dec 29, 2023 | 8.24M | -53.15% |
| Dec 30, 2022 | 17.59M | -77.16% |
| Dec 31, 2021 | 77.01M | 10.52% |
| Dec 31, 2020 | 69.68M | -29.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |